Tau pathology in Alzheimer disease and other tauopathies - Wikidata - thesis-toulmin - TriplyDB

Tau pathology in Alzheimer disease and other tauopathies

Tau pathology in Alzheimer disease and other tauopathies

http://www.wikidata.org/entity/Q22252520

about

Language performance in Alzheimer's disease and mild cognitive impairment: A comparative review Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice Protein phosphatases and Alzheimer's disease Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders Implications of GABAergic Neurotransmission in Alzheimer's Disease Alzheimer's Disease: Mechanism and Approach to Cell Therapy A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease Physiological and pathological phosphorylation of tau by Cdk5 The role of the LRRK2 gene in Parkinsonism Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro.Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?A Role of Ginseng and Its Constituents in the Treatment of Central Nervous System Disorders The ubiquitin-proteasome system in Alzheimer's disease Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation Berberine attenuates axonal transport impairment and axonopathy induced by Calyculin A in N2a cells I1PP2A affects tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39 Melatonin arrests peroxynitrite-induced tau hyperphosphorylation and the overactivation of protein kinases in rat brain Biallelic Mutations in TBCD, Encoding the Tubulin Folding Cofactor D, Perturb Microtubule Dynamics and Cause Early-Onset Encephalopathy Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells The natural history of consciousness, and the question of whether plants are conscious, in relation to the Hameroff-Penrose quantum-physical 'Orch OR' theory of universal consciousness.Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport.R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease.Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins.Mitochondrial oxidative stress causes hyperphosphorylation of tau.Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation Spectral and complexity analysis of scalp EEG characteristics for mild cognitive impairment and early Alzheimer's disease.Effects of medicinal plants on Alzheimer's disease and memory deficits.

P2860

Q22248003-32656418-609D-4905-B039-B45074A9E3B9 Q24302457-1BDF7351-4264-41B0-8EF8-B60D322E0668 Q24310830-136A219C-B0A8-471A-B41D-364EF53F9F88 Q24563378-6C70B18F-A03A-447A-858F-93389FA5640F Q24628256-21224AB7-EE1F-48DE-B432-18A2ED3A40D7 Q24632495-7F1D465A-67BE-4ED0-9BFF-3305D43D862C Q26741247-ECA4241B-A2A8-451A-A8F9-AADA77EAB486 Q26750648-E737AEB6-F6C9-45C8-B21C-714E9A0A6FF5 Q26766934-8A08B71E-AAF9-43BA-B4AC-3D3A8AB117A0 Q26768593-B0471DA0-4C2B-4788-A3E4-C3B4769CA5EF Q26778149-42DBC33D-D465-4558-B53D-1C4F1CBCAA99 Q26781496-E353F38E-25BB-43A1-8490-4722A760A155 Q26799258-3C794A7B-496B-43EA-899E-D7571F542BF3 Q26853347-87C5F8BC-2FF7-4066-9009-E164D852A23B Q26860395-98CF153D-1E60-4B48-9036-55C08EDD4057 Q27023749-CE7D8F73-8DAD-491A-AEA0-605A67C39696 Q27307725-C2204037-8E07-42E2-A12E-1E275AE0125E Q28070156-23264779-C224-4FB4-A1DD-98F447489F67 Q28072689-42EB9B22-00FA-41EE-865A-83ADC3D99CF7 Q28268311-63414267-7B4D-4117-B3CC-8390122D82DD Q28282056-E2EDF724-9012-4749-BE5A-CFDB82F8D3A6 Q28484464-4D7A46BE-8978-4CDA-88C0-D31FDB93B088 Q28534810-F3726C8F-B770-42FC-BF63-71B3A724B278 Q28537637-F406D9A0-0529-494B-9061-598331A64F2E Q28566668-ED2A8F1E-4D74-46B1-B081-ECFC3444032C Q28574229-B371E0DB-3E7E-48A9-A875-DE7E3A866104 Q28574914-15E26D21-9347-4A92-A6B5-F1A625BF1240 Q28975762-CBE21F8A-41D4-43F3-A0FE-828534169B41 Q30363322-D6C789F5-1EB8-4D4A-9FE7-80F1468F492E Q30401040-FB95D1CA-F4BD-4464-9380-FFEEA6F7C592 Q30504709-2776188D-D826-4130-B49B-1BEB1B53B74E Q30684317-FEC6D09C-A1BA-49C4-AA24-4BEDDD7CA073 Q30845482-2087CFC8-753C-4A41-875B-A46E1BEF3D3E Q30996805-E423DC35-2714-4C76-B34E-5F11CD6F1ECC Q30998279-7F915BB8-6D3A-4371-BCF2-528F9B536E82 Q33242184-2F98D32C-1EBD-4268-B4F9-D04FDE29A4AB Q33288260-3362B63F-49C3-495C-AC6F-51740E6B6871 Q33300947-7A935E6D-BAAB-4AC4-9F6B-EE9A7DCE0EB0 Q33614462-158A60CC-921D-4282-A686-ACF3978BBB1F Q33702630-7D3554D3-E6C1-48C3-9DF9-D90E19BFF835

P2860

Tau pathology in Alzheimer disease and other tauopathies

http://www.wikidata.org/entity/Q22252520

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Tau pathology in Alzheimer disease and other tauopathies

@ast

Tau pathology in Alzheimer disease and other tauopathies

@en

Tau pathology in Alzheimer disease and other tauopathies

@en-gb

Tau pathology in Alzheimer disease and other tauopathies

@nl

type

label

Tau pathology in Alzheimer disease and other tauopathies

@ast

Tau pathology in Alzheimer disease and other tauopathies

@en

Tau pathology in Alzheimer disease and other tauopathies

@en-gb

Tau pathology in Alzheimer disease and other tauopathies

@nl

prefLabel

Tau pathology in Alzheimer disease and other tauopathies

@ast

Tau pathology in Alzheimer disease and other tauopathies

@en

Tau pathology in Alzheimer disease and other tauopathies

@en-gb

Tau pathology in Alzheimer disease and other tauopathies

@nl

P1433

Q22252520-4C1E3B39-EEC2-4521-89A8-76BBB44DAB5A

P1476

Q22252520-BA9FAC3A-D714-4F37-82F5-E6B2249D8AF0

P2093

Q22252520-15C80B2C-38CE-45A4-8A0B-C683CA332A13

Q22252520-30B80B0A-7335-40B4-A112-6B0BF9ABBC67

Q22252520-5858693D-D8A9-4996-A450-9049A989F2FE

Q22252520-753B291D-6114-4484-82AD-6CB5A3D1AFF3

Q22252520-9004B8F3-2AAE-4B7A-B9C6-D2CDA499FD46

Q22252520-BAACBA57-A2C0-40F2-AD61-6899A3BF9810

Q22252520-C3811998-FC10-4B3B-AA09-D02467C436AF

Q22252520-C9307614-FB60-408B-813D-ED156F14D078

Q22252520-CA0DFF5F-37FE-499A-8F09-C461F0D46FEE

Q22252520-D728DFFA-780C-403D-BFB2-A9970EEB51EC

P304

Q22252520-50C0DCFE-5CA8-4F47-861D-AB3981976412

P31

Q22252520-67E6743C-49BA-45B9-9BE2-E624BF03E9D3

P3181

Q22252520-3351AFF2-2354-4825-8355-3CB87505F1D1

P356

Q22252520-28EBB8FB-CCB4-4BB1-8194-64F2251F5B22

P407

Q22252520-00367DBB-0C89-41D0-8827-9C038FF391C8

P433

Q22252520-B46C7FD8-85FE-4A70-B8C3-82A965986294

P478

Q22252520-859C7707-949E-43EB-A2DC-9D9DFA9C144C

P50

Q22252520-5A61EAC8-1E04-45B6-872D-6BB175335A1F

Q22252520-8F854DF1-53D5-41D1-833E-DCA20D7C6B74

P577

Q22252520-B20EAD59-6467-419D-BDE0-C815C9E85F7B

P5875

Q22252520-9C686BF8-E598-4704-B601-C31437A571B7

P698

Q22252520-6DD27DD9-4EF1-4C85-9D10-53A8FE85739E

P921

Q22252520-9A6E2D4B-8529-4A5D-A394-2A5A39BB2EED

Q22252520-fe5b2555-ffd4-4868-b97a-7e47ca4835c1

P3181

P356

J.BBADIS.2004.09.008

P1433

Biochimica et Biophysica Acta

P1476

Tau pathology in Alzheimer disease and other tauopathies

@en

P2093

Abdur Rahman

http://www.w3.org/2001/XMLSchema#string

Alejandra del C. Alonso

http://www.w3.org/2001/XMLSchema#string

Bin Li

http://www.w3.org/2001/XMLSchema#string

Ezzat El-Akkad

http://www.w3.org/2001/XMLSchema#string

Fei Liu

http://www.w3.org/2001/XMLSchema#string

Hitoshi Tanimukai

http://www.w3.org/2001/XMLSchema#string

Khalid Iqbal

http://www.w3.org/2001/XMLSchema#string

M. Omar Chohan

http://www.w3.org/2001/XMLSchema#string

Sabiha Khatoon

http://www.w3.org/2001/XMLSchema#string

She Chen

http://www.w3.org/2001/XMLSchema#string

P304

198-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

131295

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.BBADIS.2004.09.008

http://www.w3.org/2001/XMLSchema#string

P407

P433

2-3

http://www.w3.org/2001/XMLSchema#string

P478

1739

http://www.w3.org/2001/XMLSchema#string

P50

Inge Grundke-Iqbal

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8114173

http://www.w3.org/2001/XMLSchema#string

P698

15615638

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease